Literature DB >> 34398502

Thoracic Sertoli-Leydig cell tumor: An alternative type of pleuropulmonary blastoma associated with DICER1 variation.

William Terry1, Erica M Carlisle2, Paige Mallinger3,4,5, Alexander T Nelson3,4,5, David Gordon1, Yoav H Messinger3,4,5, Amanda Field6, Louis P Dehner7, D Ashley Hill8, Kris Ann P Schultz3,4,5.   

Abstract

A 2-year-old boy presented with a large cystic and solid chest mass arising from the lung, radiographically consistent with pleuropulmonary blastoma (PPB). He underwent right lower lobectomy with resection of a well-circumscribed, mixed solid and cystic mass. The solid areas were composed of cords and nests of tumor cells in the myxoid stroma and retiform foci whose pathologic and immunophenotypic findings were consistent with a sex cord-stromal tumor with features of a Sertoli-Leydig cell tumor. Tumor testing showed a pathogenic variant in the DICER1 RNase IIIb hotspot domain. Family history was suggestive of DICER1 germline pathogenic DICER1 variation in absence of a detectable germline variant. He received 12 cycles of chemotherapy with ifosfamide, vincristine, dactinomycin and doxorubicin (IVADo) and surgery with complete response. One year after completion of chemotherapy, imaging studies showed concern for recurrence confirmed by thorascopic biopsy of a pleural-based mass. He is currently receiving cisplatin-based chemotherapy with reduction in tumor size. Review of the literature showed no similar cases; however, review of our pathology files revealed a single similar case of anterior mediastinal Sertoli cell tumor in a 3-year-old girl.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  DICER1; Sertoli-Leydig cell tumor; pleuropulmonary blastoma; thoracic tumor

Mesh:

Substances:

Year:  2021        PMID: 34398502      PMCID: PMC8463509          DOI: 10.1002/pbc.29284

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  19 in total

1.  Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in DICER1 syndrome: a unique variant of the two-hit tumor suppression model.

Authors:  Mark Brenneman; Amanda Field; Jiandong Yang; Gretchen Williams; Leslie Doros; Christopher Rossi; Kris Ann Schultz; Avi Rosenberg; Jennifer Ivanovich; Joyce Turner; Heather Gordish-Dressman; Douglas Stewart; Weiying Yu; Anne Harris; Peter Schoettler; Paul Goodfellow; Louis Dehner; Yoav Messinger; D Ashley Hill
Journal:  F1000Res       Date:  2015-07-10

2.  DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry.

Authors:  Kris Ann P Schultz; Anne K Harris; Michael Finch; Louis P Dehner; Jubilee B Brown; David M Gershenson; Robert H Young; Amanda Field; Weiying Yu; Joyce Turner; Nicholas G Cost; Dominik T Schneider; Douglas R Stewart; A Lindsay Frazier; Yoav Messinger; D Ashley Hill
Journal:  Gynecol Oncol       Date:  2017-10-14       Impact factor: 5.482

3.  Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: a report from the International Pleuropulmonary Blastoma Registry.

Authors:  Kris Ann P Schultz; M Cristina Pacheco; Jiandong Yang; Gretchen M Williams; Yoav Messinger; D Ashley Hill; Louis P Dehner; John R Priest
Journal:  Gynecol Oncol       Date:  2011-04-17       Impact factor: 5.482

4.  Sex-Cord Stromal Tumors in Children and Teenagers: Results of the TGM-95 Study.

Authors:  Brice Fresneau; Daniel Orbach; Cécile Faure-Conter; Cécile Verité; Marie Pierre Castex; Nicolas Kalfa; Hélène Martelli; Catherine Patte
Journal:  Pediatr Blood Cancer       Date:  2015-07-23       Impact factor: 3.167

5.  Testicular Sertoli cell tumour and potentially testicular Leydig cell tumour are features of DICER1 syndrome.

Authors:  Lisa Golmard; Lauren M Vasta; Douglas R Stewart; Nicolas Sirvent; Valérie Duflos; Carole Corsini; Catherine Dubois d'Enghien; Mary L McMaster; Laura A Harney; Ann G Carr; Alexander Ling; Frédérique Dijoud; Arnaud Gauthier; Markku Miettinen; Nicholas G Cost; Marion Gauthier-Villars; Daniel Orbach; Sabine Irtan; Stéphanie Haouy; Kris Ann Schultz; Dominique Stoppa-Lyonnet; Isabelle Coupier
Journal:  J Med Genet       Date:  2021-03-29       Impact factor: 6.318

6.  Pleuropulmonary Blastoma: More Than a Lung Neoplasm of Childhood.

Authors:  Louis P Dehner; Kris Ann Schultz; D Ashley Hill
Journal:  Mo Med       Date:  2019 May-Jun

7.  DICER1 mutations in familial pleuropulmonary blastoma.

Authors:  D Ashley Hill; Jennifer Ivanovich; John R Priest; Christina A Gurnett; Louis P Dehner; David Desruisseau; Jason A Jarzembowski; Kathryn A Wikenheiser-Brokamp; Brian K Suarez; Alison J Whelan; Gretchen Williams; Dawn Bracamontes; Yoav Messinger; Paul J Goodfellow
Journal:  Science       Date:  2009-06-25       Impact factor: 47.728

Review 8.  Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases.

Authors:  R H Young; R E Scully
Journal:  Am J Surg Pathol       Date:  1985-08       Impact factor: 6.394

9.  A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors.

Authors:  Niamh Conlon; Anne M Schultheis; Salvatore Piscuoglio; Annacarolina Silva; Esther Guerra; Carmen Tornos; Victor E Reuter; Robert A Soslow; Robert H Young; Esther Oliva; Britta Weigelt
Journal:  Mod Pathol       Date:  2015-10-02       Impact factor: 7.842

10.  Primary mesenteric sertoli-leydig cell tumor: a case report and review of the literature.

Authors:  Amel Trabelsi; Soumaya Ben Abdelkarim; Mohamed Hadfi; Ridha Fatnaci; Wided Stita; Badreddine Sriha; Sadok Korbi
Journal:  J Oncol       Date:  2008-10-30       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.